Valerie Edmond

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms.

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms.

Journal: Journal of thrombosis and haemostasis : JTH
Published: March 06, 2024

Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.

Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.

Journal: Blood advances
Published: September 21, 2023

Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.

Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.

Journal: Blood cancer journal
Published: April 19, 2023

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.

Journal: Leukemia
Published: December 02, 2022

In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.

In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.

Journal: Blood cancer discovery
Published: March 02, 2021

JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML.

JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML.

Journal: The Journal of experimental medicine
Published: June 18, 2020

PPARγ agonists promote the resolution of myelofibrosis in preclinical models.

PPARγ agonists promote the resolution of myelofibrosis in preclinical models.

Journal: The Journal of clinical investigation
Published: January 23, 2020

Dual role of EZH2 in megakaryocyte differentiation.

Dual role of EZH2 in megakaryocyte differentiation.

Journal: Blood
Published: December 19, 2019

Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN.

Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN.

Journal: Nature communications
Published: November 15, 2019

Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.

Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.

Journal: Oncogene
Published: September 19, 2013

Staphylococcus aureus-induced G2/M phase transition delay in host epithelial cells increases bacterial infective efficiency.

Staphylococcus aureus-induced G2/M phase transition delay in host epithelial cells increases bacterial infective efficiency.

Journal: PloS one
Published: December 10, 2012

Precise mapping of the CD95 pre-ligand assembly domain.

Precise mapping of the CD95 pre-ligand assembly domain.

Journal: PloS one
Published: June 11, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026